August 8, 2017 / 8:57 PM / 5 months ago

BRIEF-Cellular Biomedicine Q2 ‍loss per share $0.43​

Aug 8 (Reuters) - Cellular Biomedicine Group Inc:

* Cellular Biomedicine Group reports second quarter and first half 2017 financial results and business highlights

* Cellular Biomedicine Group Inc - ‍cash and cash equivalents as of June 30, 2017 were $27.3 million compared to $39.3 million as of December 31, 2016​

* Cellular Biomedicine Group Inc qtrly ‍loss per share $0.43​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below